Walter Reinisch

机构：Medical University of Vienna

发表论文 405 篇 · 总被引 14845 次 · h-index 52

代表论文

• Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study (2024 · The Lancet · 被引 108)
• Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn’s Disease: A Post Hoc Analysis of 3 Phase 3 Trials (2024 · Clinical Gastroenterology and Hepatology · 被引 48)
• Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspective (2024 · United European Gastroenterology Journal · 被引 21)
• Assessment of outcomes in Crohn's disease: A systematic review of randomized clinical trials to inform a multiple outcome framework (2024 · United European Gastroenterology Journal · 被引 9)
• Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial (2026 · ˜The œLancet. Gastroenterology & hepatology · 被引 3)
• Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial (2026 · ˜The œLancet. Gastroenterology & hepatology · 被引 3)